Deep sleep is when growth hormone release peaks naturally
[30] Why States Are Cutting Coverage State Medicaid programs are facing unsustainable costs from GLP-1 medications: Wegovy costs ~$1,350/month at list pricemultiplied across thousands of beneficiaries [6] Medicaid drug spending on GLP-1s has increased dramatically since 2020 [1] Budget constraints force states to make difficult coverage decisions Unlike commercial insurance , states can't spread costs across a broader risk pool According to KFF, states that do cover GLP-1s for obesity report significant budget impacts, leading several to reconsider or restrict coverage going forward
Last month, CBS News documented how, without regulatory approval, retatrutide has gone viral online and was being widely prescribed by licensed medical professionals
It's important to note that you should never stop taking prescribed Wegovy solely to become eligible for donation
The broader side effect landscape for GLP-1 compounds is explored in resources about semaglutide constipation management , tirzepatide digestive side effects , and tirzepatide and anxiety